![]() |
Name |
Andrastin B
|
Molecular Formula | C28H40O7 | |
IUPAC Name* |
methyl (3S,5S,8S,9R,10S,13R,14R)-3-acetyloxy-17-hydroxy-10-(hydroxymethyl)-4,4,8,12,13,16-hexamethyl-15-oxo-2,3,5,6,7,9-hexahydro-1H-cyclopenta[a]phenanthrene-14-carboxylate
|
|
SMILES |
CC1=C[C@@H]2[C@](CC[C@H]3[C@]2(CC[C@@H](C3(C)C)OC(=O)C)CO)([C@]4([C@@]1(C(=C(C4=O)C)O)C)C(=O)OC)C
|
|
InChI |
InChI=1S/C28H40O7/c1-15-13-19-25(6,28(23(33)34-8)22(32)16(2)21(31)26(15,28)7)11-9-18-24(4,5)20(35-17(3)30)10-12-27(18,19)14-29/h13,18-20,29,31H,9-12,14H2,1-8H3/t18-,19-,20+,25+,26+,27+,28-/m1/s1
|
|
InChIKey |
DZXRNRBENGRMTG-OXILWVMOSA-N
|
|
Synonyms |
Andrastin B; CHEBI:142862; methyl (3beta,5beta,8alpha,9beta,10alpha,13alpha)-3-(acetyloxy)-15,19-dihydroxy-4,4,8,12,16-pentamethyl-17-oxoandrosta-11,15-diene-14-carboxylate; methyl (3S,5S,8S,9R,10S,13R,14R)-3-acetyloxy-17-hydroxy-10-(hydroxymethyl)-4,4,8,12,13,16-hexamethyl-15-oxo-2,3,5,6,7,9-hexahydro-1H-cyclopenta[a]phenanthrene-14-carboxylate; methyl 3beta-(acetyloxy)-15,19-dihydroxy-4,4,8,12,16-pentamethyl-17-oxo-5beta,8alpha,9beta,10alpha,13alpha-androsta-11,15-diene-14-carboxylate
|
|
CAS | NA | |
PubChem CID | 10368235 | |
ChEMBL ID | NA |
Chemical Classification: |
|
|
---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
---|---|---|---|---|---|---|---|---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
Molecular Weight: | 488.6 | ALogp: | 4.0 |
HBD: | 2 | HBA: | 7 |
Rotatable Bonds: | 5 | Lipinski's rule of five: | Accepted |
Polar Surface Area: | 110.0 | Aromatic Rings: | 4 |
Heavy Atoms: | 35 | QED Weighted: | 0.332 |
Caco-2 Permeability: | -5.303 | MDCK Permeability: | 0.00002310 |
Pgp-inhibitor: | 0.985 | Pgp-substrate: | 0.229 |
Human Intestinal Absorption (HIA): | 0.017 | 20% Bioavailability (F20%): | 0.12 |
30% Bioavailability (F30%): | 0.938 |
Blood-Brain-Barrier Penetration (BBB): | 0.62 | Plasma Protein Binding (PPB): | 65.62% |
Volume Distribution (VD): | 0.506 | Fu: | 30.63% |
CYP1A2-inhibitor: | 0.005 | CYP1A2-substrate: | 0.813 |
CYP2C19-inhibitor: | 0.022 | CYP2C19-substrate: | 0.845 |
CYP2C9-inhibitor: | 0.038 | CYP2C9-substrate: | 0.05 |
CYP2D6-inhibitor: | 0.001 | CYP2D6-substrate: | 0.095 |
CYP3A4-inhibitor: | 0.687 | CYP3A4-substrate: | 0.833 |
Clearance (CL): | 3.607 | Half-life (T1/2): | 0.432 |
hERG Blockers: | 0.003 | Human Hepatotoxicity (H-HT): | 0.24 |
Drug-inuced Liver Injury (DILI): | 0.595 | AMES Toxicity: | 0.063 |
Rat Oral Acute Toxicity: | 0.34 | Maximum Recommended Daily Dose: | 0.102 |
Skin Sensitization: | 0.025 | Carcinogencity: | 0.687 |
Eye Corrosion: | 0.93 | Eye Irritation: | 0.105 |
Respiratory Toxicity: | 0.981 |
Similar NPs | Similar Drugs | ||||||
---|---|---|---|---|---|---|---|
NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
ENC001949 | ![]() |
0.828 | D0H2MO | ![]() |
0.299 | ||
ENC004115 | ![]() |
0.806 | D0V2JK | ![]() |
0.287 | ||
ENC003138 | ![]() |
0.655 | D04GJN | ![]() |
0.280 | ||
ENC002033 | ![]() |
0.632 | D0X4RS | ![]() |
0.276 | ||
ENC005963 | ![]() |
0.617 | D0X7XG | ![]() |
0.273 | ||
ENC003457 | ![]() |
0.614 | D02CNR | ![]() |
0.271 | ||
ENC005965 | ![]() |
0.603 | D08TEJ | ![]() |
0.265 | ||
ENC005964 | ![]() |
0.534 | D08BDT | ![]() |
0.259 | ||
ENC001980 | ![]() |
0.372 | D06AEO | ![]() |
0.254 | ||
ENC001833 | ![]() |
0.343 | D0IX6I | ![]() |
0.254 |